Form 8-K - Current report:
SEC Accession No. 0001193125-20-174730
Filing Date
2020-06-22
Accepted
2020-06-22 07:12:03
Documents
6
Period of Report
2020-06-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d949919d8k.htm 8-K 45342
2 EX-10.1 d949919dex101.htm EX-10.1 150381
3 EX-23.1 d949919dex231.htm EX-23.1 1734
4 EX-99.1 d949919dex991.htm EX-99.1 11433
5 GRAPHIC g949919001.jpg GRAPHIC 11316
6 GRAPHIC g949919002.jpg GRAPHIC 9521
  Complete submission text file 0001193125-20-174730.txt   228560
Mailing Address 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862
Business Address 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862 978 671-8001
Lantheus Holdings, Inc. (Filer) CIK: 0001521036 (see all company filings)

EIN.: 352318913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36569 | Film No.: 20977161
SIC: 2835 In Vitro & In Vivo Diagnostic Substances